THE ROLE OF INTELLECTUAL PROPERTY RIGHTS IN THE (UN)AVAILABILITY OF VACCINES DURING THE PANDEMIC
Abstract: Intellectual property law is dedicated to promoting inventions, while ensuring the protection of socio-economic interests. The financial aspects of research and the lack of alternative protection for investments impose the need for their patent protection. Many countries, especially developing ones, have resisted the patent protection of pharmaceutical products, fearing that these products would become inaccessible to them, as patent protection increases the price of medicines. However, it is exactly the rules of intellectual property that, through the institute of compulsory licensing, enable the renunciation of the monopoly over pharmaceutical products, in the time of epidemics and pandemics. The institute of compulsory licensing in the period of pandemics gives priority to human lives over the profits of several pharmaceutical companies. The question then arises as to why countries such as the EU, the United States and others rebelled within the WTO against the proposal of South America, Africa and India to implement the institute of compulsory licensing for covid-19 vaccines.
2. CARER D., 2011, “Drug Production, Public Interest vs. Intellectual property rights“, Yale Journal of Medicine and Law, 18.02.2010., Vol. VI, issue 2, www.yalemed.law.com/2010/02-drug-production-public-interest-w-i.p.r.
3. IDRIS K., 2003, Intelektualna svojina, mocno sredstvo ekonomskog rasta, Beograd.
4. LARRIMORE O., Stanfords Lisa Ouellette on Waiving COVID-19 Vaccine Patents, https://law.stanford.edu/2021/05/04/.
5. MARKOVIĆ S., 1997, Patentno pravo, Beograd.
6. MARKOVIĆ S., 2007, O nedopustenoj retroaktivnosti zakona na primeru patentibilnosti pronalaska lekova u pravu Republike Srbije, Pravo I privreda 5-8, 595-608.
7. Pravo farmaceutskih kompanija na dobit ne može biti iznad prava na zdravlje! https://www.dw.com/sr/treba-li-uvesti-prisilne-licence-za-vakcine/a-56498483
8. Potential WTO TRIPS Waiver and COVID-19 Updated September 13, 2021 https://crsreports.congress.gov/product/pdf/IF/IF11858.
9. ROBIN J. 2011., Patents and farmaceuticals- a paper given on 29 th November at the Presentation of the Directorate General of Competitions preliminary report of the pharma sector inquiry, www.europa.eu/…/pharmaceuticals/jacobs.pdf.
10. SARABOH, TESANKIC, 2009, Uslovi za sticanje, kriterijumi patentibilnosti.
11. VLASKOVIĆ, B., 1989, Patentna zastita pronalazaka iz oblasti hemije, Pronalazastvo, Beograd.
12. WTO-Intellectual property, TRIPS and public health, http//www.wto.org/english/trips /pharmpatent-e-htm. ŽIVKOVIC V., 2008, Patenti i investicije, Beograd.